Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome (Leukemia, 2020)

(untitled) - Hoeks, M; Bagguley, T; van Marrewijk, C; Smith, A; Bowen, D; Culligan, D; Kolade, S; Symeonidis, A; Garelius, H; Spanoudakis, M; Langemeijer, S; Roelofs, R; et al.